For purposes of this Article XX, the following terms have the following meanings:
“CAAP” means the County Adult Assistance Programs, set forth in Article VII of Chapter 20 of the Administrative Code.
“City” means the City and County of San Francisco.
“CLIA” means the Clinical Laboratory Improvement Amendments, codified at 42 U.S.C. § 263a, as may be amended from time to time, and including any implementing regulations.
“CND Participant” means a person participating in the Cash Not Drugs Pilot Program and meeting the eligibility criteria in Section 20.20-3.
“DPH” means the San Francisco Department of Public Health.
“Drug Test” means a test that detects the presence of illicit substances without referral to or analysis by a CLIA laboratory, such as but not limited to a rapid, at-home test or testing by a non-CLIA certified forensic laboratory.
“Executive Director” means the Executive Director of HSA or the Executive Director’s designee.
“HSA” means the San Francisco Human Services Agency.
“MAT” means Medication-Assisted Treatment.
“Negative Drug Test” means a Drug Test that is negative for any of the controlled substances listed in California Health and Safety Code Section 11054, as may be amended from time to time, with the exception of the following substances: Cannabis; Psilocybin; Psilocyn; Dimethyltryptamine (DMT); Mescaline; or any controlled substance used in connection with a prescribed MAT program, including, but not limited to, Buprenorphine and Methadone.
“Pilot Program” means the Cash Not Drugs Pilot Program, as set forth in this Article XX.
(Added by Ord. 257-24, File No. 240799, App. 11/14/2024, Eff. 12/15/2024)